Efficacy of Extracorporeal Magnetic Stimulation, Pelvic Floor Muscle Exercise, and Combination of Both in Management of Post Radical Prostatectomy Urinary Incontinence

Sponsor
Hamad General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05680168
Collaborator
(none)
60
1
3
84
0.7

Study Details

Study Description

Brief Summary

Urinary incontinence is one of the most common complications of radical prostatectomy. Multiple prevention and treatment modalities have been proposed in the management of post prostatectomy urinary incontinence. This is a randomized controlled comparative study to evaluate the efficacy of extracorporeal magnetic stimulation alone and combined with pelvic floor muscle exercise versus pelvic floor muscle exercise alone in the management of post radical prostatectomy urinary incontinence. This study is expected to be performed over 7 years. The study population will be all male patients who are prepared for radical prostatectomy under urology department in HMC and were referred to voiding dysfunction for preoperative counselling and postoperative rehabilitation. Patients will be randomized into one of three treatment groups. The first group will receive sessions of extracorporeal magnetic field stimulation only. The second group will receive extracorporeal magnetic stimulation in addition to pelvic floor muscle exercise. The third group will receive pelvic floor muscle exercise only. The recruitment phase will take 3 years. Patients will be followed for 18 months for the course of urinary incontinence symptoms, severity of urinary incontinence on 1-hour pad test, urodynamic leak point pressure and the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) and the ICIQ quality of life (QOL) score. This study is proposed to reveal strong evidence on the efficacy of extracorporeal magnetic stimulation on the management of post radical prostatectomy urinary incontinence.

Condition or Disease Intervention/Treatment Phase
  • Device: Extracorporeal electromagnetic stimulation
  • Behavioral: Pelvic floor exercises
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Efficacy of Extracorporeal Magnetic Stimulation, Pelvic Floor Muscle Exercise, and Combination of Both in Management of Post Radical Prostatectomy Urinary Incontinence: A Randomized Controlled Trial
Actual Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2029
Anticipated Study Completion Date :
Dec 31, 2029

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group A: Extracorporeal Magnetic stimulation

Group (A): will receive rehabilitation program with exposure to ExMS, Patients will receive regular sessions of electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia). Each session will last for 20 minutes. Patients will receive three weekly sessions for total of 20 sessions starting one month after catheter removal.

Device: Extracorporeal electromagnetic stimulation
Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).

Active Comparator: Group B: Extracorporeal Magnetic stimulation and pelvic floor exercises

Group (B): This group will receive a rehabilitation program depending ExMS with the protocol described above. In addition, this group will be advised for pelvic floor muscle training in serial training sessions with our therapist for PME.

Device: Extracorporeal electromagnetic stimulation
Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).

Behavioral: Pelvic floor exercises
Pelvic floor muscle training in serial training sessions with our therapist

Active Comparator: Group C: Pelvic floor exercises

Group (C): This will be the control group. This group will be advised to do PME only. The pelvic floor exercises will consist of advice to the patients to contract the anal sphincter muscles in successive way as if holding flatus. The pelvic floor muscle training schedule and therapist in group B and group C will be the same.

Behavioral: Pelvic floor exercises
Pelvic floor muscle training in serial training sessions with our therapist

Outcome Measures

Primary Outcome Measures

  1. One hour pad test [18 months from the start of intervention]

    Measuring the weight of an incontinence pad used for one hour to detect the volume of urinary leakage in one hour assessed at 6 points of follow up

  2. the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) [18 months from the start of intervention]

    Questionnaire administered at 6 points of follow up

  3. Urodynamic leak point pressure. [1 day (Once) after 6 weeks of the start of rehabilitation process]

    Urodynamic study to evaluate the bladder dynamics and its response to radical prostatectomy and its response to rehabilitation

Secondary Outcome Measures

  1. International Consultation on Incontinence Questionnaire quality of life score [18 months from the start of intervention]

    Questionnaire administered at 6 points of follow up

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • The study population will include all adult male patients 18 years of age and above, with localized prostate cancer of low or intermediate risk disease who chose definitive treatment with radical prostatectomy either through open radical retropubic prostatectomy (RRP) or through robotic assissted laparoscopic radical prostatectomy (RALP) as first line for treatment and had the surgery under Hamad General Hospital urology department care.
Exclusion Criteria:
  • Patients with high risk , locally advanced or metastatic prostate cancer at time of diagnosis

  • Patients with low to intermediate risk prostate cancer who received chemo or radiotherapy then had salvage surgery

  • Patients with urinary incontinence or diagnosed overactive bladder before radical prostatectomy.

  • Patients with complicated surgery resulting in anastomotic leak, prolonged catheterisation more than 3 weeks, reinsertion of catheter due to retention of urine.

  • Patients who refuse to participate in the clinical trial.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ambulatory Care Center Doha Qatar

Sponsors and Collaborators

  • Hamad General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ahmed Albakr, Principal Investigator, Hamad General Hospital
ClinicalTrials.gov Identifier:
NCT05680168
Other Study ID Numbers:
  • MRC0122185
First Posted:
Jan 11, 2023
Last Update Posted:
Jan 13, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ahmed Albakr, Principal Investigator, Hamad General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 13, 2023